mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.07 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.08 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.08 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |